An Open-Label, 2-Way Crossover Study To Investigate The Pharmacokinetics, Safety And Tolerability Of IV CP-70429 And Oral PF-03709270 In Subjects With Varying Degrees Of Renal Impairment And Normal Renal Function.

Trial Profile

An Open-Label, 2-Way Crossover Study To Investigate The Pharmacokinetics, Safety And Tolerability Of IV CP-70429 And Oral PF-03709270 In Subjects With Varying Degrees Of Renal Impairment And Normal Renal Function.

Completed
Phase of Trial: Phase I

Latest Information Update: 30 Jan 2016

At a glance

  • Drugs Sulopenem; Sulopenem
  • Indications Bacterial infections
  • Focus Pharmacokinetics
  • Most Recent Events

    • 28 Apr 2010 Actual number of patients changed from 21 to 29 as reported by ClinicalTrials.gov record.
    • 28 Apr 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 12 Feb 2010 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top